CD4+/Leu-7+ LARGE GRANULAR LYMPHOCYTES IN LONG-TERM RENAL ALLOGRAFT RECIPIENTS A SUBSET OF ATYPICAL T CELLS1
- 1 June 1989
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 47 (6) , 964-970
- https://doi.org/10.1097/00007890-198906000-00010
Abstract
In long-term renal allograft recipients on conventional immunosuppression, we have previously reported an abnormal expansion of CD3+/Leu-7+ cells. These cells are large granular lymphocytes without any natural killer activity. About 20% of these CD3+/Leu-7+ cells coexpress the CD4 differentiation antigen. In 65 transplant recipients at risk for more than 6 months, the mean percentage of peripheral blood CD4+/Leu-7+ cells is significantly increased compared with 34 normals (5.0 .+-. 0.6% versus 1.0 .+-. 0.1%, P < 0.0001). Patients who never received azathioprine do not show such an abnormality. We carried out this study to further define the phenotype, morphology, and function of these cells. As to phenotype, they coexpress CD2, CD3 but do not coexpress CD1, CD8, CD11, CD16, CD19, CD25, HLA-DR, Leu-M3. Morphologically, CD4+/Leu-7+ cells are typical large granular lymphocytes undistinguishable from CD16+ effector NK cells. CD4+/Leu-7+ cells do not exhibit any natural killer cell activity. In contrast to CD4+/Leu-7- cells, CD4+/Leu-7+ cells do not proliferate when stimulated with either lectins (Con A, PHA) or allogeneic cells. When stimulated for 3 days with PHA, sorted CD4+/Leu-7+ cells do not express IL-2 receptors as detected with a PE-conjugated anti-CD25 monoclonal antibody, whereas 40% of CD4+-Leu-7- cells do so. Finally, when stimulated with PHA, CD4+-Leu-7+ cells are not able to produce detectable levels of IL-2, while CD4+-Leu-7- cells do so. In long-term renal allograft recipients on conventional immunosuppression, Leu-7 antigen identifies a subset of CD4+ cells that do not behave like regular T helper cells. We speculate that these cells represent an alterations in the cellular environment in transplant recipients, perhaps leading to long-term complications such as cancers and chronic viral infections.This publication has 23 references indexed in Scilit:
- A Unique Human B Lymphocyte Antigen Defined by a Monoclonal AntibodyHybridoma, 1984
- Characterization of a phenotypically distinct subpopulation of Leu-2+ cells that suppresses T cell proliferative responses.The Journal of Immunology, 1983
- Transient expression of interleukin 2 receptors. Consequences for T cell growth.The Journal of Experimental Medicine, 1983
- Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens.The Journal of Immunology, 1983
- Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1.The Journal of Immunology, 1983
- A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1).The Journal of Immunology, 1981
- A human T lymphocyte differentiation marker defined by monoclonal antibodies that block E-rosette formation.The Journal of Immunology, 1981
- Evolutionary conservation of surface molecules that distinguish T lymphocyte helper/inducer and cytotoxic/suppressor subpopulations in mouse and manThe Journal of Experimental Medicine, 1981
- Two populations of Ia-like molecules on a human B cell line.The Journal of Immunology, 1980
- DISSOCIATION OF NATURAL KILLER CELL ACTIVITY AND ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY IN KIDNEY ALLOGRAFT RECIPIENTS RECEIVING HIGH-DOSE IMMUNOSUPPRESSIVE THERAPYTransplantation, 1980